Summary
Early in the 20th century changes in appetite and weight had already been recognized as important features of severe psychiatric disorders. The present chapter reviews recent evidence suggesting that the fat cell-derived hormone leptin is pathophysiologically involved in these changes. Moreover, data are discussed supporting the speculation that leptin, which is now recognized to be a cytokine-like peptide involved in many aspects of brain function such as neurodevelopment, neuronal survival and various aspects of behavior and cognition, plays a patho-physiological role in behavioral and cognitive changes observed in psychiatric patients and, in particular, in anorexia nervosa and schizophrenia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, Weiden PJ, Cheskin LJ (1999a) The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiat 60:215–220
Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999b) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiat 156:1686–1996
Auwerx J, Staels B (1998) Leptin. Lancet 351:737–742
Beumont PJ, Arthur B, Russell JD, Touyz SW (1994) Excessive physical activity in dieting disorder patients: proposals for a supervised exercise program. Intl J Eat Disord 15:21–36
Brömel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C, Remschmidt H, Krieg JC, Hebebrand J (1998) Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiat 3:76–80
Bukanan R (2000) Schizophrenia: introduction and overview. In: Sadock B, Sadock V (eds) Comprehensive textbook of psychiatry. Lippincott Williams & Wilkins, New York, pp 1096–1109
Bustillo JR, Buchanan RW, Irish D, Breier A (1996) Differential effect of clozapine on weight: a controlled study. Am J Psychiat 153:817–819
Devuyst O, Lambert M, Rodhain J, Lefebvre C, Coche E (1993) Haematological changes and infectious complications in anorexia nervosa: a case-control study. Q J Med 86:791–799
Dicou E, Attoub S, Gressens P (2001) Neuroprotective effects of leptin in vivo and in vitro. Neuroreport 12:3947–3951
Eder U, Mangweth B, Ebenbichler C, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Fleischhacker WW (2001) Association of olanzapine-induced weight gain with an increase in body fat. Am J Psychiat 158:1719–1722
Esler M, Vaz M, Collier G, Nestel P, Jennings G, Kaye D, Seals D, Lambert G (1998) Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet 351(9106):879
Exner C, Hebebrand J, Remschmidt H, Wewetzer C, Ziegler A, Herpertz S, Schweiger U, Blum WF, Preibisch G, Heldmaier G, Klingenspor M (2000) Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa. Mol Psychiat 5:476–481
Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukocyte Biol 68:437–446
Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O’Rahilly S (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879–884
Hebebrand J, Ballauff A, Hinney A, Herpertz S, Köpp W, Wewetzer C, Ziegler A, Blum WF, Remschmidt H (1999) Die gewichtsregulation im rahmen der Anorexia nervosa unter besonderer berücksichtigung der leptinsekretion. Nervenarzt 70:31–40
Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568–1575
Hinze-Selch D, Schuld A, Kraus T, Kühn M, Uhr M, Haack M, Pollmächer T (2000) Effects of antidepressants on weight and on the plasma levels of leptin, TNF-α and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 23(1):13–19
Jalenques I, Tauveron I, Albuisson E, Audy V, Fleury-Duhamel N, Codert A (1996) Weight gain as a predictor of long-term clozapine efficiency. Clin Drug Invest 12:16–25
Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Rev 20:68–100
Karsenty G (2001) Leptin controls bone formation through a hypothalamic relay. Recent Prog Horm Res 56:401–415
Köpp W, Blum WF, von Prittwitz S, Ziegler A, Lubbert H, Emons G, Herzog W, Herpertz S, Deter HC, Remschmidt H, Hebebrand J (1997) Low leptin levels predict amenorrhea in underweight and eating disordered females. Mol Psychiat 2:335–340
Köpp W, Blum WF, Ziegler A, Mathiak K, Lubbert H, Herpertz S, Deter HC, Hebebrand J (1998) Serum leptin and body weight in females with anorexia and bulimia nervosa. Horm Metab Res 30:272–275
Kraepelin E (1901) Einführung in die psychiatrische klinik. Dreissig Vorlesungen. Barth Verlag, Leipzig
Kraus T, Haack M, Schuld A, Hinze-Selch D, Kühn M, Uhr M, Pollmächer T (1999) Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiat 156:312–314
Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmächer T (2001) Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 73:243–247
Kraus T, Zimmermann U, Schuld A, Haack M, Hinze-Selch D, Pollmächer T (2001) Zur pathophysiologie der gewichtsregulation im rahmen der thérapie mit Psychopharmaka. Fortschritte der Neurologie-Psychiatrie 69:116–137
Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmächer T (2002) Body weight, the tumor necrosis factor system and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry, in press.
Lieberman JA (1999) Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiat 46:729–739
Maier W, Lichtermann D, Rietschel M, Held T, Falkai P, Wagner M, Schwab S (1999) [Genetics of schizophrenic disorders. New concepts and findings]. Nervenarzt 70:955–969
Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S, Nakao K (1997) Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing’s syndrome. J Clin Endocrin Metab 82:2542–2547
Meltzer HY, Lee MA, Ranjan R (1994) Recent advances in the pharmacotherapy of schizophrenia. Acta Psychiatr Scand 384:95–101
Morimoto T, Yamamoto Y, Yamatodani A (2001) Brain histamine and feeding behavior. Behav Brain Res 124:145–150
Newcomer JW, Selke G, Melson AK, Gross J, Vogler GP, Dagogo-Jack S (1998) Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans. Arch Gen Psychiat 55:995–1000
Pickar D (1995) Prospects for pharmacotherapy of schizophrenia. Lancet 345:557–562
Pollmächer T (2002) Treatment of schizophrenia. In: Smelser NJ, Balters PB (eds) International Encyclopedia of the social and behavioral sciences. Pergamon, Kidlington, pp 13546–13552
Rayner DV, Trayhurn P (2001) Regulation of leptin production: sympathetic nervous system interactions. J Mol Med 79:8–20
Schafroth U, Godang K, Ueland T, Bollerslev J (2001) Leptin response to endogenous acute stress is independent of pituitary function. Eur J Endocrinol 145:295–301
Shanley LJ, Irving AJ, Harvey J (2001) Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neuroscience 21(24):RC186
Sinton CM, Fitch TE, Gershenfeld HK (1999) The effects of leptin on REM sleep and slow wave delta in rats are reversed by food deprivation. J Sleep Res 8:197–203
Steppan CM, Swick AG (1999) A role for leptin in brain development. Biochem Biophys Res Commun 256:600–602
Wauters M, Considine RV, Van Gaal LF (2000) Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143:293–311
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Pollmächer, T. (2002). An Emerging Role of Leptin in Clinical Psychiatry. In: Kordon, C., Robinson, I., Hanoune, J., Dantzer, R., Christen, Y. (eds) Brain Somatic Cross-Talk and the Central Control of Metabolism. Research and Perspectives in Endocrine Interactions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18999-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-18999-9_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62400-1
Online ISBN: 978-3-642-18999-9
eBook Packages: Springer Book Archive